FDA — authorised 26 November 1954
- Status: approved
🇺🇸 Md-76R in United States
FDA authorised Md-76R on 26 November 1954
Marketing authorisations
FDA — authorised 29 September 1989
- Application: NDA019292
- Marketing authorisation holder: LIEBEL-FLARSHEIM
- Local brand name: MD-76R
- Indication: INJECTABLE — INJECTION
- Status: approved
Md-76R in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Nephrology approved in United States
Frequently asked questions
Is Md-76R approved in United States?
Yes. FDA authorised it on 26 November 1954; FDA authorised it on 29 September 1989.
Who is the marketing authorisation holder for Md-76R in United States?
University of California, San Francisco is the originator. The local marketing authorisation holder may differ — check the official source linked above.